CNC.NYSECentene CORP

Form 4: Centene Director Kenneth Burdick Reports Acquisition of 500 Shares and Indirect Ownership Details

Sentiment:

SEC Form 4 Filing


Director Kenneth Burdick reports acquiring 500 shares of Centene Corp common stock and details indirect ownership through the Burdick Family LLC.

Summary

  • Kenneth A. Burdick, a director of Centene Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On March 31, 2025, Mr. Burdick acquired 500 shares of Centene common stock at $0.
  • Following the transaction, Mr. Burdick directly owns 362,917.924 shares, including 2,916 shares of restricted stock units subject to vesting requirements.
  • Mr. Burdick also indirectly owns 86,498 shares through the Burdick Family LLC, where he serves as chief manager.
  • He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
  • Mr. Burdick also owns options to buy 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a company director. The acquisition of shares is a mildly positive signal, but the disclaimer of beneficial ownership of shares held by the family LLC tempers any strong positive interpretation.

Positives

  • The director's acquisition of shares may signal confidence in the company's future prospects.

Management Comments

  • Mr. Burdick disclaims beneficial ownership of the securities held by the Burdick Family LLC except to the extent of his pecuniary interest.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Comparing Burdick's holdings and transactions to those of other directors in similarly sized healthcare companies could provide context on whether his actions are typical or indicative of a specific outlook.
  • For example, reviewing Form 4 filings of directors at UnitedHealth Group (UNH) or Anthem (ANTM) could offer a benchmark.

Stakeholder Impact

  • The director's stock transactions can influence investor sentiment and potentially impact the stock price.

Key Dates

DateDescription
02/07/2025Date Common Stock Option (right to buy) becomes exercisable
03/31/2025Date of transaction: Acquisition of 500 shares of common stock.
02/07/2032Expiration date of Common Stock Option (right to buy)
04/02/2025Date of report filing.

Keywords

Centene, CNC, Form 4, Beneficial Ownership, Director, Kenneth Burdick, Stock Acquisition, Restricted Stock Units, Stock Options, Burdick Family LLC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.